Baseline and On-Treatment Dynamics of Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Immune-Phenotype Biomarkers in Advanced Gastric Cancer Patients Receiving Ramucirumab (ESMO-IO 2026) - Oct 25, 2026 - Abstract #28P; Pres time: Dec 14, 2026; 05:30 PM - 06:30 PM; Location: Churchill Room; No abstract available
Biomarker • Clinical • Metastases • Gastric Cancer • Oncology • Solid Tumor
|
|
Paul A. Milea; Claudia C. Burz; Calin I. C ainap
|